Eli Lilly to inject $1 billion in new contract manufacturing facilities in India; to set up new manufacturing & quality hub in Hyderabad

Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen global supply capabilities and leverage India’s skilled talent pool for producing life-changing medicines, reinforcing Hyderabad’s position as a healthcare innovation hub.